Jerzy Gumulka - 19 Apr 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-Fact
Issuer symbol
CNSP
Transactions as of
19 Apr 2023
Net transactions value
+$4,250
Form type
4
Filing time
21 Apr 2023, 07:58:55 UTC
Previous filing
17 Apr 2023
Next filing
12 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $4,250 +2,500 +35% $1.70 9,673 19 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.